Primary Role
CSO at Isogenica

Detailed Description

Update

Chris Ullman joined Isogenica in 2002 and since then has been heavily involved in the development of the company's CIS display technology. Prior to joining Isogenica, Chris was Team Leader for Gendaq Ltd. (later acquired by Sangamo Biosciences Inc.), developing customised transcription factors. The company was spun-out from Sir Aaron Klug's Laboratory at the LMB, Cambridge.

Experience (1)

Update